Novo Nordisk
NVO
NVO
558 hedge funds and large institutions have $7.89B invested in Novo Nordisk in 2018 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 162 increasing their positions, 199 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.36% more ownership
Funds ownership: 17.17% → 17.53% (+0.36%)
19% less repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 199
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
558
Holding in Top 10
8
Calls
$78.9M
Puts
$21.7M
Top Buyers
| 1 | +$70.6M | |
| 2 | +$26.3M | |
| 3 | +$24.7M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.6M |
| 5 |
Millennium Management
New York
|
+$20.6M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$27.3M | |
| 3 | -$20.8M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$19.8M |
| 5 |
Jane Street
New York
|
-$14.4M |